DENTSPLY SIRONA Reports Decline in Q2 2026 Sales but Net Income Recovery

DENTSPLY SIRONA Inc. reported a decline in financial performance for the second quarter of 2026, with net sales totaling $898 million, down from $936 million in the same period of 2025. For the first half of 2026, net sales reached $1.778 billion, compared to $1.815 billion in the prior year. The company recorded a net income of $37 million, or $0.18 per diluted share, a significant recovery from a net loss of $45 million, or $(0.22) per diluted share, in the second quarter of 2025. The improved profitability was attributed to tariff refunds and favorable foreign currency impacts, despite lower sales volumes and unfavorable pricing in certain segments.

The company experienced notable changes in its operational metrics compared to the previous fiscal period. The Connected Technology Solutions segment saw a decrease in net sales, primarily due to lower volumes of CAD/CAM products in the Americas and unfavorable pricing in EMEA. The Orthodontic and Implant Solutions segment was particularly affected by the absence of Byte products, leading to a 13.2% decline in sales for the quarter. In contrast, the Wellspect Healthcare segment reported a 7.1% increase in sales, driven by new product introductions and higher volumes in EMEA.

DENTSPLY SIRONA has been actively restructuring its operations, with a new plan approved in February 2026 aimed at improving performance and driving shareholder value. The company has incurred $57 million in non-recurring restructuring charges related to this plan, which is expected to yield approximately $120 million in annualized cost savings. The restructuring efforts are part of a broader strategy to reinvest in growth initiatives, including innovation and sales team education.

In terms of operational indicators, the company reported a decrease in cash and cash equivalents to $239 million as of June 30, 2026, down from $326 million at the end of 2025. The total employee headcount remained stable, with no significant changes reported. The company also noted a decrease in accounts receivable days to 61 days, indicating improved cash flow management. However, inventory days increased to 136 days, reflecting challenges in inventory turnover.

Looking ahead, DENTSPLY SIRONA anticipates continued challenges due to macroeconomic conditions, including inflation and geopolitical tensions, which may impact consumer confidence and discretionary spending. The company remains focused on mitigating these risks through strategic pricing and supply chain management. The outlook for the remainder of 2026 suggests cautious optimism, with expectations for gradual recovery in sales as the company implements its restructuring plan and capitalizes on new product offerings.